Bristol Myers Squibb Stock Price - BMY

-0.10 (-0.19%)
Upgrade to Real-Time
Afterhours (Closed)
Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
Small Cap Basic
Monthly Subscription
for only
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
VAT not included
Company Name Stock Ticker Symbol Market Type
Bristol Myers Squibb Co BMY NYSE Common Stock
  Price Change Change Percent Stock Price Low Price High Price Open Price Close Price Last Traded
0.54 1.03% 52.79 50.87 53.78 51.11 52.25 20:00:00
Stock Trades Traded Volume VWAP Dollar Volume Average Volume 52 Week Range
113,744 14,498,371 $ 52.00 $ 753,919,062 18,021,576 41.19 - 68.34
Last Trade Time Type Quantity Stock Price Currency
19:58:33 10 $ 52.69 USD

Bristol Myers Squibb Financials

Market Cap Shares in Issue Profit/Loss Earnings Per Share (EPS) PE Ratio Float
$ 119.44B 2.26B $ 4.92B 2.00 26.10 2.26B
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
45.17M $ 1.68 3.18% 04/02/20 - -

more financials information »

Bristol Myers Squibb News

Loading Messages....

Latest BMY Messages

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical BMY Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week49.0553.7845.7649.3620,251,8333.747.62%
1 Month57.8061.8545.7654.2120,701,395-5.01-8.67%
3 Months62.6168.3445.7659.9616,324,136-9.82-15.68%
6 Months50.0168.3445.7658.5816,807,2122.785.56%
1 Year48.2668.3441.1953.1515,244,6794.539.39%
3 Years55.6070.0541.1954.1910,528,349-2.81-5.05%
5 Years65.1977.1241.1956.239,449,879-12.40-19.02%

Bristol Myers Squibb Description

Bristol-Myers Squibb Co discovers, develops, and markets drugs for various indications, such as cardiovascular, oncology, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is leading in drug development. Unlike some of its more diversified peers, Bristol has exited several nonpharmaceutical businesses to focus on branded specialty drugs, which tend to support strong pricing power.

Your Recent History
Gulf Keyst..
FTSE 100
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.